Dianthus Therapeutics | MGTA - EPS Earnings Per Share


Dianthus Therapeutics reported $-0.9 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.





Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
Avita Medical AUD -0.25 0.13 Jun/2026
Celltrion KRW 1.35K 224.25 Jun/2026
Cspc Pharmaceutical CNY 0.08 0.08 Mar/2026
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -0.9 0.05 Jun/2026
Divis Laboratories Ltd INR 42.49 18.47 Sep/2026
IQVIA Holdings USD 3.34 0.19 Sep/2026
Kangmei Pharma CNY 0 0.01 Jun/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Moderna USD 0.38 2.35 Sep/2026
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD 0.77 0.78 Jun/2026
Organon & Co USD 0.6 0.2 Sep/2026
Ovoca Bio EUR 0 0.06 Dec/2025
Pharma Mar EUR 0.47 0.31 Sep/2026
Qiagen NV USD 0.58 0.04 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Sartorius EUR 1.16 0.21 Sep/2026
Sino Biopharmaceutical CNY 0.19 0.25 Jun/2026
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.71 0.02 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026
Zealand Pharma A/S -5.58 2.76 Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.22 0.25 Sep/2026